Risultati della ricerca - Jingyang Lin

Cost-effectiveness analysis of anlotinib versus sunitinib as first-line treatment for metastatic renal cell carcinoma in China. di Jingyang Lin, Qingxia Fang, Xiaochun Zheng

Testo

Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression di Qingxia Fang, Jingyang Lin, Liang Gao, Ruolang Pan, Xiaochun Zheng

Testo

Safety assessment of proteasome inhibitors real world adverse event analysis from the FAERS database di Jinlong Huang, Miaomiao Zhang, Jingyang Lin, Xiuli Yang, Ping Huang, Xiaochun Zheng

Testo

Real-world safety profile of zanubrutinib: a disproportionality analysis based on the FAERS database di Ping Huang, Xiaochun Zheng, Miaomiao Zhang, Jiangfeng Wang, Jingyang Lin, Jinlong Huang, Xiuli Yang

Testo